Resources
The HRA is currently reviewing all its website material to ensure greater consistency in the use of language in conveying standards that should be followed (ethical obligations or best practice) or must be followed (legal requirements). Readers should be aware that the HRA holds both in high regard. For further information please see the HRA website conditions which can be found here.
Resources pages provide additional detail on important topics. This includes links to external sites, reference documents and explanatory text.
Many pages also provide links to other areas of the site, where related information can be found.
We have created these to give you extra detail on key themes, and many of them can be reached from more than one page in the site.
You can find information in this section using the alphabetical list below, the categories in the menu on the left or using the search box.
List of Resources
- Adding new sites to a study
- Administration of Radioactive Substances
- Adults Unable to Consent for Themselves
- Amendments
- Applying for Approvals: Template Documents
- Care After Research
- Central Booking Service (CBS)
- Chief Investigator
- Clinical Research Networks
- Clinical Trials of Investigational Medicinal Products (CTIMPs)
- Confidentiality Advisory Group (CAG) – frequently asked questions
- Confidentiality Advisory Group (CAG) – determining the need for a CAG application
- Confidentiality Advisory Group (CAG) – meeting dates
- Confidentiality Advisory Group (CAG) – precedent set criteria
- Confidentiality Advisory Group (CAG) – considerations and application guidance
- Confidentiality Advisory Group (CAG) – security review arrangements
- Confidentiality Advisory Group (CAG) – form for non-research applications
- Confidentiality Advisory Group (CAG) – standard conditions of approval
- Confidentiality Advisory Group (CAG) – annual review template
- Confidentiality Advisory Group (CAG) – amendment form
- Confidentiality, Privacy and Data Protection
- Consent and Participant Information
- End of Study Notification – Clinical Trials of Investigational Medicinal Products (CTIMPs): EudraCT form
- End of Study Notification – Studies other than Clinical Trials of Investigational Medicinal Products
- Ethical Considerations in Research
- Ethical Review for Private and Voluntary Health Care
- Ethical Review of Clinical Trials of Investigational Medicinal Products
- Ethical Review of Investigations of Medical Devices
- Ethical Review of Research in Residential Care Homes
- Ethical Review of Research Involving Adults Unable to Consent for Themselves
- Ethical Review of Research Involving Exposure to Ionising Radiation
- Ethical Review of Research Involving Human Tissue
- Ethical Review of Research Involving Practising Midwives
- Ethical Review of Research Involving the HFEA Register
- Ethical Review of Research using Confidential Patient Information
- Four Nations
- Gene Therapy Advisory Committee (GTAC)
- Governance Arrangements for Research Ethics Committees (GAfREC)
- Health Research Authority Complaints Policy
- Higher Education Institution Research Ethics Committees
- HRA Assessment and Standards Criteria
- Human Tissue
- Integrated Research Application System (IRAS)
- International Research
- Ionising Radiation
- Is it Research?
- Is NHS REC review required?
- Legal Requirements for Research Ethics Review
- Medical Devices Research
- Memorandum of understanding – Human Tissue Authority / NRES
- Memorandum of understanding – MHRA Medicine / NRES
- Ministry of Defence (MoD) Research Ethics Committee
- National Social Care Research Ethics Committee
- NHS/HSC R&D – notification of non-substantial/minor amendment form
- NHS / HSC R&D review or permission
- NHS/HSC R&D – UK process for management of amendments
- NHS R&D resources
- NHS Research Ethics Committee (REC) – Appeals
- NHS Research Ethics Committee (REC) – Annual Progress Report Forms
- NHS Research Ethics Committee (REC) – Application Process Flowchart
- NHS Research Ethics Committee (REC) – Central Allocation System (CAS)
- NHS Research Ethics Committee (REC) – CTIMP safety report form
- NHS Research Ethics Committee (REC) – Directory
- NHS Research Ethics Committee (REC) – Local Allocation System (LAS)
- NHS Research Ethics Committee (REC) – Proportionate Review Allocation System
- NHS Research Ethics Committee (REC) – Review Outcomes
- NHS Research Ethics Committee (REC) – Submitting a response to provisional opinion
- NHS Research Ethics Committee (REC) – Where to Book
- NHS Research Ethics Committee (REC) Review – International Research
- NHS site set-up in England
- NREAP Guidance
- Participant Identification Centres
- Personal Data in Research
- Phase I Trials
- Principal Investigator
- Progress and Safety Reporting
- Public involvement in research
- Raising concerns about a Research Ethics Committee (REC)
- Raising concerns about the National Research Ethics Service (NRES)
- REC Member Recruitment Policy
- Regenerative Medicine
- Research Databases
- Research Funding
- Research Governance Frameworks
- Research requiring NHS R&D review but not ethical review
- Research summary
- Research Tissue Banks
- Researcher Suitability and Training
- Scientific Review of Research
- Site-Specific Assessment (SSA)
- Sponsor
- Sponsor’s Legal Representative
- Standard Operating Procedures
- Statement of Activities and Schedule of Events
- Student Research
- Study titles
- Study Types
- Transparency, registration and publication
- Working between HFEA & CAG – HFEA registry data
- World Medical Association Declaration of Helsinki
- Questions and Answers – Medical Devices
- Questions and Answers – Mental Capacity Act 2005
- Questions and Answers – The Human Tissue Act 2004